Showing items 1–100
Single domain antibodies that bind to CD137
Grant US-12077595-B2
United States of America
AAV-mediated delivery of antibodies to the inner ear
Grant US-12077783-B2
United States of America
Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and…
Grant US-12065498-B2
United States of America
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
Grant US-12060436-B2
United States of America
Camelidae single-domain antibodies against Yersinia pestis and methods of use
Grant US-12030931-B2
United States of America
Camelidae single-domain antibodies against Yersinia pestis and methods of use
Grant US-12030930-B2
United States of America
Camelidae single-domain antibodies against Yersinia pestis and methods of use
Grant US-12030932-B2
United States of America
Methods of treating aging-related disorders
Grant US-12024545-B2
United States of America
Single-chain chimeric polypeptides and uses thereof
Grant US-12018071-B2
United States of America
OX40-binding polypeptides and uses thereof
Grant US-12012459-B2
United States of America
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory…
Grant US-12006355-B2
United States of America
Camelidae single-domain antibodies against Yersinia pestis and methods of use
Grant US-11987618-B2
United States of America
Single-chain chimeric polypeptides and uses thereof
Grant US-11987619-B2
United States of America
Multispecific binding constructs against checkpoint molecules and uses thereof
Grant US-11970538-B2
United States of America
sdAb-CBM FUSION PROTEIN BOUND TO POLYSACCHARIDE POLYMER
Application WO-2024079210-A1
World Intellectual Property Organisation (WIPO)
Anti-age antibodies for treating neurodegenerative disorders
Grant US-11958900-B2
United States of America
Therapeutic molecules that bind to LAG3 and PD1
Grant US-11951172-B2
United States of America
Antibodies against microorganisms and uses thereof
Grant US-11939371-B2
United States of America
Specific binding molecules
Grant US-11919949-B2
United States of America
TfR selective binding compounds and related methods
Grant US-11918647-B2
United States of America
Single-domain antibodies and variants thereof against TIGIT
Grant US-11905327-B2
United States of America
Camelidae single-domain antibodies against Yersinia pestis and methods of use
Grant US-11891433-B2
United States of America
Multi-chain chimeric polypeptides and uses thereof
Grant US-11884712-B2
United States of America
Method and composition for treating sarcopenia
Grant US-11872269-B2
United States of America
Product and method for treating sarcopenia
Grant US-11873345-B2
United States of America
Compositions and methods for CAR T cell therapy
Grant US-11850262-B2
United States of America
CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
Grant US-11851497-B2
United States of America
Method and composition for treating cancer, killing metastatic cancer cells and…
Grant US-11833202-B2
United States of America
Single domain antibodies to programmed cell death (PD-1)
Grant US-11814429-B2
United States of America
Methods of use for CAR T cells
Grant US-11779602-B2
United States of America
Compositions and methods for CAR T cell therapy
Grant US-11759480-B2
United States of America
Agonist antibodies that bind human CD137 and uses thereof
Grant US-11752207-B2
United States of America
Therapeutic targeting of non-cellular structures
Grant US-11753463-B2
United States of America
Multi-chain chimeric polypeptides and uses thereof
Grant US-11738052-B2
United States of America
Methods for stimulating proliferation or differentiation of an immune cell with a multi-cha…
Grant US-11730762-B2
United States of America
CD137 antibodies and PD-1 antagonists and uses thereof
Grant US-11718679-B2
United States of America
Single-domain antibodies and variants thereof against PD-1
Grant US-11713353-B2
United States of America
Immunoglobulin variable domains
Grant US-11708404-B2
United States of America
Bi-functional chimeric proteins and uses thereof
Grant US-11702477-B2
United States of America
POLYPEPTIDES DIRECTED AGAINST VIRAL INFECTION AND USES THEREOF
Application US-20230218656-A1
United States of America
AAV-mediated delivery of therapeutic antibodies to the inner ear
Grant US-11697801-B2
United States of America
Methods of treating aging-related disorders
Grant US-11672826-B2
United States of America
Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
Grant US-11661455-B2
United States of America
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
Grant US-11649288-B2
United States of America
Single domain antibodies to programmed cell death protein 1 (PD-1)
Grant US-11591398-B2
United States of America
ANTIGEN-BINDING POLYPEPTIDES AGAINST CD39
Application WO-2023021185-A1
World Intellectual Property Organisation (WIPO)
ANTIGEN-BINDING POLYPEPTIDES AGAINST CD39
Application EP-4137516-A1
European Patent Office
Humanized monoclonal advanced glycation end-product antibody
Grant US-11542324-B2
United States of America
Methods and compositions for treating diabetes and diabetic complications
Grant US-11518801-B1
United States of America
CX3CR1-BINDING POLYPEPTIDES
Application EP-4050027-A3
European Patent Office
Immunoglobulin variable domains
Grant US-11485777-B2
United States of America
Immunoglobulin variable domains
Grant US-11485778-B2
United States of America
Single-domain antibodies and variants thereof against CTLA-4
Grant US-11472881-B2
United States of America
Multispecific antigen binding proteins and methods of use thereof
Grant US-11447573-B2
United States of America
Single-chain chimeric polypeptides and uses thereof
Grant US-11401324-B2
United States of America
CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
Grant US-11384151-B2
United States of America
ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF
Application EP-3802592-A4
European Patent Office
Heterodimeric antibodies that bind CD3 and CD38
Grant US-11352442-B2
United States of America
MOLECULE SPECIFICALLY BINDING TO CLDN18.2
Application WO-2022111425-A1
World Intellectual Property Organisation (WIPO)
Immunoglobulin variable domains
Grant US-11319364-B2
United States of America
Methods of use for CAR T cells
Grant US-11311576-B2
United States of America
Pseudomonas aeruginosa PcrV binding single variable domain antibodies
Grant US-11312788-B2
United States of America
Immunoglobulin variable domains
Grant US-11312765-B2
United States of America
Immunoglobulin variable domains
Grant US-11312764-B2
United States of America
Single-domain antibodies to programmed cell death 1 protein (PD-1), encoding nucleic…
Grant US-11312771-B2
United States of America
Methods, compositions and apparatuses for facilitating regeneration
Grant US-11261241-B2
United States of America
CD20 binding single domain antibodies
Grant US-11248057-B2
United States of America
Targeted mutant interferon-beta and uses thereof
Grant US-11236141-B2
United States of America
CD8 binding agents
Grant US-11236166-B2
United States of America
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory…
Grant US-11225514-B2
United States of America
Immunoglobulin variable domains
Grant US-11220539-B2
United States of America
Vaccines for use in treating various diseases and disorders
Grant US-11213585-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRS and uses…
Grant US-11162953-B2
United States of America
Protein binding domains stabilizing functional conformational states of GPCRs and uses…
Grant US-11162954-B2
United States of America
Method for treating rheumatoid arthritis by administering IL-6 receptor antibodies
Grant US-11149089-B2
United States of America
Chimeric polypeptides and methods of altering the membrane localization of the same
Grant US-11111310-B2
United States of America
Amino acid sequences directed against RANK-L and polypeptides comprising the same for the…
Grant US-11078290-B2
United States of America
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
Grant US-11078296-B2
United States of America
Multispecific binding constructs against checkpoint molecules and uses thereof
Grant US-11046769-B2
United States of America
Pharmaceutical compositions comprising a polypeptide that binds to IL-6
Grant US-11008393-B2
United States of America
Clec9A binding agents
Grant US-11001631-B2
United States of America
Methods and compositions for treating disease-related cachexia
Grant US-10995151-B1
United States of America
Bispecific signaling agents and uses thereof
Grant US-10988538-B2
United States of America
Methods and compositions for treating pain associated with inflammation
Grant US-10961321-B1
United States of America
Selective removal of cells having accumulated agents
Grant US-10960234-B2
United States of America
Vaccines for use in treating juvenile disorders associated with inflammation
Grant US-10925937-B1
United States of America
Humanized monoclonal advanced glycation end-product antibody
Grant US-10919957-B2
United States of America
Stable heterodimeric antibody design with mutations in the Fc domain
Grant US-10875931-B2
United States of America
Methods and compositions for treating osteoarthritis
Grant US-10858449-B1
United States of America
NOVEL CLDN18.2 BINDING MOLECULE
Application WO-2020238730-A1
World Intellectual Property Organisation (WIPO)
Single variable domain antibodies against OX40L, constructs and therapeutic use
Grant US-10822425-B2
United States of America
Expression of a single chain antibody against Salmonella in Lactobacillus
Grant AU-2015237933-B2
Australia
Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amylo…
Grant US-10738109-B2
United States of America
TfR selective binding compounds and related methods
Grant US-10722576-B2
United States of America
EXPRESSION OF A SINGLE CHAIN ANTIBODY AGAINST SALMONELLA IN LACTOBACILLUS
Grant EP-3122773-B1
European Patent Office
Recombinant immunotoxin targeting mesothelin
Grant US-10683362-B2
United States of America
SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST CTLA-4
Application EP-3526258-A4
European Patent Office
Methods for the treatment of interleukin-6 receptor-related diseases and disorders
Grant US-10618966-B2
United States of America
Nanobody against IL-6R
Grant US-10618964-B2
United States of America
Showing items 1–100